• Users Online: 126
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 3  |  Issue : 2  |  Page : 43-48

Effect of omega-3 supplementation on serum adiponectin and fertility hormones in women with polycystic ovarian syndrome


1 Department of Chemical Pathology, Nnamdi Azikiwe University, Nnewi, Nigeria
2 Department of Chemical Pathology, Chukwuemeka Odumegwu Ojukwu University, Awka, Anambra, Nigeria
3 Department of Medical Laboratory Sciences, Nnamdi Azikiwe University, Nnewi, Nigeria

Correspondence Address:
Chikaodili Nwando Obi-Ezeani
Department of Chemical Pathology, Chukwuemeka Odumegwu Ojukwu University, Awka, Anambra
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jascp.jascp_8_22

Rights and Permissions

Background: Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age with prevalence of about 4%–20%. Aim: This study aims to evaluate serum adiponectin and fertility hormones in women with PCOS, and the subsequent effect of omega-3 supplementation. Subjects and Methods: One hundred and fifty women aged 18–40 years were assigned into groups A and B comprising women with PCOS and control, respectively. Group A was further subdivided into groups 1 and 2 receiving omega-3 and placebo daily for 12 weeks, respectively. Blood samples were collected before and after 12 weeks of supplementation for analysis of adiponectin, follicle stimulating hormone (FSH), luteinizing hormone (LH), testosterone, prolactin, estradiol, progesterone, and sex hormone binding globulin (SHBG). Statistical Package for Social Sciences (SPSS) version 23.0 was used for data analysis, and the level of statistical significance was set at P < 0.05. Results: Serum adiponectin, progesterone, and SHBG were significantly lower while FSH, LH, testosterone, prolactin, and estradiol were significantly higher in women with PCOS when compared with the control (P < 0.05). Adiponectin and progesterone levels increased significantly while FSH, LH, testosterone, prolactin, and estradiol levels decreased significantly after 12 weeks of omega-3 supplementation when compared with the levels at baseline as well as when compared with those on placebo (P < 0.05). Statistical Package for Social Sciences (SPSS) version 23.0 was used for data analysis. Conclusion: Omega-3 may be beneficial in improving certain hormonal alterations in women with PCOS. Omega-3 supplements may therefore be used as part of the regimen in the management of patients with PCOS.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed74    
    Printed4    
    Emailed0    
    PDF Downloaded4    
    Comments [Add]    

Recommend this journal